Buccal drug delivery systems represent an innovative strategy for the administration of therapeutic agents via the oral mucosa. This approach bypasses the hepatic first‐pass metabolism, thereby ...
Key market opportunities in the oral transmucosal drugs sector include expanding use in opioid dependence, seizures, and pain management, driven by needle-free dosing preference and film technology ...
Oral medication administration in older adults encompasses a range of challenges and innovative solutions aimed at improving therapeutic outcomes in an ageing population. Age-related physiological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results